Skip to content

Study on the pathogenesis of otosclerosis

Study on the pathogenesis of otosclerosis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042582
Enrollment
Unknown
Registered
2021-01-23
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otosclerosis

Interventions

otosclerosis group vs. healthy control goup:None

Sponsors

Eye & ENT hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: Patients with clinical diagnosis of otosclerosis.

Exclusion criteria

Exclusion criteria: Patients with other malformations of the inner or middle ear, combined diseases will affect the results of this study and the health of patients.

Design outcomes

Primary

MeasureTime frame
Exon sequencing of genomic DNA;

Countries

China

Contacts

Public ContactDongdong Ren

Eye & ENT Hospital of Fudan University

dongdong_ren@163.com+86 13801913332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026